Collateral Ligament Stabilizer System Market To Reach $3.21 Billion By 2030

Collateral Ligament Stabilizer System Market Growth & Trends

The global collateral ligament stabilizer system market size is anticipated to reach USD 3.21 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 6.4% from 2024 to 2030. An increase in the number of sports injuries and road accidents is expected to boost the adoption of Collateral Ligament Stabilizer System (CLSS). According to Stanford Children’s Health, around 3.5 million children aged 14 years and below are affected by some form of sport-related injury every year. This shows the potential demand for CLSS in the coming years.

Nearly one-third of all injuries affecting children arise due to sport-related activities. Sports Medicine Australia also estimated that 1 in 17 Australians suffer from sports trauma each year. According to the Zurich American Insurance Company, 62% of the injuries related to organized sports occur during practices. Thus, increasing sports-related injuries has resulted in the high demand for collateral ligament stabilizer systems.

According to WHO, every year nearly 1.25 million people die due to road accidents and about 20 to 50 million are injured. Thus, the rise in the number of road accidents is anticipated to heighten the adoption of CLSS.

Furthermore, the increasing geriatric population across the globe is another major factor propelling the growth of the CLSS market. According to a report published by the U.S. Census Bureau, Japan has the highest percentage of the aging population in the world. In 2015, about 26.6% of the population in Japan was aged 65 years and over, which accounted for nearly 33.7 million people.

 Request a free sample copy or view report summary: Collateral Ligament Stabilizer System Market Report

Collateral Ligament Stabilizer System Market Report Highlights

• The medial collateral ligament dominated the market and accounted for the largest revenue share of 58.7% in 2023. The (Medial Collateral Ligament) MCL is a crucial stabilizer of the knee joint, offering protection against rotational and valgus forces.

• Grade III dominated the market with the largest revenue share of 38.7% in 2023. The grade III ligament tear is a severe tear in which the collateral ligament is completely torn, both deep parts

• The surgical treatment segment is expected to grow at a CAGR of 6.6% over the projected years. The exact recovery period from surgery depends upon the tear's severity and other knee injuries.

• The North America collateral ligament stabilizer system market dominated the global market and accounted for the largest revenue share of 42.1%.

Collateral Ligament Stabilizer System Market Segmentation

Grand View Research has segmented the global collateral ligament stabilizer system market report based on ligament, injury, treatment, end use, and region.

Collateral Ligament Stabilizer System Ligament Outlook (Revenue, USD Million, 2018 - 2030)

• Medial Collateral Ligament (MCL)

• Lateral Collateral Ligament (LCL)

Collateral Ligament Stabilizer System Injury Outlook (Revenue, USD Million, 2018 - 2030)

• Grade I

• Grade II

• Grade III

Collateral Ligament Stabilizer System Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Surgical Treatment

• Non-Surgical Treatment

Collateral Ligament Stabilizer System End use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Orthopedic Clinics

• Others

Collateral Ligament Stabilizer System Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List Of Key Players in the Collateral Ligament Stabilizer System Market

• DePuy Synthes

• Arthrex, Inc.

• Bauerfeind USA Inc.

• Ossur

• Enovis Corporation

• Orthofix Medical, Inc.

• Bio Dynamic Technologies

• DARCO International, Inc.

• DeRoyal Industries, Inc.

• Corin Group